|
Biotech News
PRESS RELEASE ARCHIVES FROM SEND2PRESS® NEWSWIRE
NOTICE: THIS IS ARCHIVAL CONTENT AND LIKELY OUT OF DATE.
Edited for Send2Press by Carly Zander
Health Discovery Corporation Announces Agreement with the University of Miami for Biomarker and Pathway Discovery in AIDS related Dementia
SAVANNAH, GA - March 23, 2004 /Send2Press Newswire/ -- Health Discovery Corporation (OTC Bulletin Board:
HDVY) today announced the signing of an Agreement with The University of Miami to use Health Discovery
Corporations proprietary and patent protected Fractal Genomics Modeling (FGM) techniques to identify new
patterns of biomarkers in AIDS Related Dementia. It is hoped that this newly discovered information will
allow physicians to better understand the pathogenesis of AIDS Related Dementia and will assist in the
diagnosis and treatment of this devastating disease.
Under the terms of the Agreement, The University of
Miami has granted Health Discovery Corporation joint ownership on any product, invention, discovery or
new use arising out of or developed by Health Discovery Corporation utilizing its unique computational
methods.
"We are honored that our Company was again selected by yet another major United States medical center to
utilize our unique approach to systems biology; this time to discover new patterns of biomarkers and
pathways associated with AIDS Related Dementia," stated Stephen D. Barnhill, M.D., Chairman and Chief
Executive Officer of Health Discovery Corporation. "We look forward to working with Dr. Shapshak and his
colleagues Drs. Carol Petito, Jorge Torres-Munoz, and Avindra Nath at U of Miami and Johns Hopkins
Medical Center on this very important discovery opportunity."
Dr. Paul Shapshak commented, "Applying the Fractal non-linear information methodology is the most
exciting technology in modern science and takes us into the 22nd Century. I am thankful and excited to
work with Dr. Barnhill and his team at Health Discovery Corporation in this endeavor. They will have a
leadership role in gene expression, bioinformatics and other new methods to defeat disease."
Dr. Shapshak
continued, "Diseases of the present and future beware!"
Estimates of the incidence of HIV-associated dementia vary, depending on the definition of dementia being
used. Researchers from the John Hopkins University have estimated that 15% of HIV-infected people may
develop dementia and that 30% may show some signs of neurological impairment (McArthur 1999).
Health Discovery Corporation is a systems biology oriented biomarker and pathway discovery company, which
uses proprietary advanced mathematical platforms, such as Fractal Genomics Modeling (FGM) techniques, to
help identify and characterize diagnostic targets and therapeutic candidates. Focusing on disease vs.
normal, within complex genomic, proteomic and clinical data sets, Health Discovery Corporation was
established to provide pharmaceutical and diagnostic companies with a broad range of analytical and
decision support solutions to accelerate effective diagnostic and drug discovery.
Founded in September
2003, the Company has offices in Texas, Georgia, and California. For more information contact Robert S.
Braswell IV of Health Discovery Corporation +1-866-953-9031 or Info@healthdiscoverycorp.com.
Organization Website: www.healthdiscoverycorp.com
Source of News:
Health Discovery Corporation
Find More Stock Info, Charts, News on OTC BB: HDVY
• Yahoo!® Finance (HDVY.OB)
• Previous News from Health Discovery Corporation (HDVY)
FOR INFORMATION ABOUT THE COMPANY OR ORGANIZATION(S) MENTIONED IN THE ABOVE BUSINESS NEWS ARTICLE, PLEASE CONTACT THE COMPANY DIRECTLY AND NOT THIS WEBSITE.
DISCLAIMER: the above business news article is believed accurate but not guaranteed, and is based on business news supplied by the company or organization mentioned and/or quoted in the story. The organization providing the news to Send2Press is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements and public companies should be thoroughly researched before considering material investment. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article.
USE OF THE ABOVE NEWS ARTICLE
Article is Copr. © 2004 Neotrope/Send2Press. Reproduction of this news article in any form requires written authorization. You may freely link to this article. For more information on using this article in print or on your website, please visit:
www.freeNewsArticles.com™.
|
